Levocarnitine and Methotrexate sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levocarnitine (levocarnitine) and Methotrexate sodium (methotrexate sodium). Common drug interactions include bacteraemia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Levocarnitine and Methotrexate sodium. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

What is Methotrexate sodium?

Methotrexate sodium has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 97,679 Methotrexate sodium users. Check the latest studies of Methotrexate sodium.

On Jul, 20, 2026

17 people who take Levocarnitine and Methotrexate sodium together, and have interactions are studied.

Levocarnitine and Methotrexate sodium drug interactions.

What are the common drug interactions of Levocarnitine and Methotrexate Sodium, by gender? *:

female:

Bacteraemia (presence of bacteria in the blood)

male:

Febrile neutropenia (fever with reduced white blood cells)
Cellulitis (infection under the skin)
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Headache (pain in head)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic failure (liver failure)
Liver disorder (liver diseases)
Nausea (feeling of having an urge to vomit)
Neutropenia (an abnormally low number of neutrophils)
Oedema peripheral (superficial swelling)

What are the common drug interactions of Levocarnitine and Methotrexate Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Febrile neutropenia (fever with reduced white blood cells)

10-19:

Decreased appetite
Diarrhoea
Enterocolitis infectious
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Headache (pain in head)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic failure (liver failure)
Liver disorder (liver diseases)
Nausea (feeling of having an urge to vomit)
Neutropenia (an abnormally low number of neutrophils)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Diarrhoea
Renal injury (kidney injury)

60+:

n/a

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 15 people, 88.24%
Blood Pressure Abnormal: 2 people, 11.76%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.88%
Neuropathy Peripheral (surface nerve damage): 1 person, 5.88%
Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 5.88%
Gastric Ph Decreased: 1 person, 5.88%
Bacterial Infection: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Levocarnitine and Methotrexate sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously